Infinium Pharmachem Ltd

NSE: INFINIUM · Pharmaceuticals & Biotechnology · 16 announcements

Share price: ₹305.50
Market cap: ₹425.1 Cr
Revenue (annual): ₹189.6 Cr
Net profit (annual): ₹12.15 Cr
P/E (TTM): 35.0×Sector 47.3×
Promoter holding: 64.91%
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 2 Financial Results 2 Board Meeting Date 2 Annual General Meeting 2 SME to Main Board Migration 1 Management Change 1 Legal & Regulatory 1 Fund Raise 1 Credit Rating 1 Business Update 1 Board Meeting Outcome 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

13 Apr 2026 16:29 IST NSE

Fund Raise

Infinium Pharmachem Fund Raise of ₹42 Cr

Infinium Pharmachem Limited clarified exchange queries regarding its FY25 financial results. The company provided a chartered accountant's certificate confirming the utilization of ₹42.00 Crore from public and preferential issue proceeds. It also clarified that segment-wise reporting is not applicable as it operates in a single business segment.

Value: ₹42.00 Cr

Read the filing ↗